ZEB1 and breast carcinoma: These results were not unique to tamoxifen; ZEB1 overexpression in MCF-7 cells and ZEB1 knockdown in MDA-MB-231 cells also reduced and enhanced, respectively, cell sensitivity to fulvestrant (Supplementary Figure S3), revealing that ectopic ZEB1 confers antiestrogen resistance in breast cancer cells.